SCHEMBL5014754

SCHEMBL5014754

CCCCCNc1ncnc2c1sc1nc(N3CCOCC3)c3c(c12)CCOC3

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 11/20 0.78
KDM4E B2RXH2 3/20 0.66
LMNA P02545 3/20 0.66
ALDH1A1 P00352 2/20 0.66
KMT2A Q03164 2/20 0.66
RAD52 P43351 1/20 0.66
POLB P06746 1/20 0.66
HTT P42858 1/20 0.66
L3MBTL1 Q9Y468 1/20 0.66
ADRB2 P07550 2/20 0.65
GAA P10253 1/20 0.65
HPGD P15428 1/20 0.65
PDE4A P27815 3/20 0.61
PDE4D Q08499 3/20 0.61
CYP2C9 P11712 1/20 0.57
CYP2C19 P33261 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
RXFP1 Q9HBX9 1/20 0.57
THRB P10828 1/20 0.57
MEN1 O00255 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5015874 0.95 PDE4B (0.70) PDE4BKDM4ELMNAALDH1A1KMT2A
SCHEMBL5011359 0.88 PDE4B (1.00) PDE4BKDM4ELMNAALDH1A1KMT2A
SCHEMBL5011526 0.87 ADRB2 (0.82) PDE4BLMNAALDH1A1KMT2ARAD52
SCHEMBL5012378 0.84 PDE4B (0.93) PDE4BKDM4ELMNAALDH1A1KMT2A
SCHEMBL5012419 0.84 ADRB2 (0.83) PDE4BLMNAALDH1A1KMT2ARAD52
SCHEMBL5012461 0.80 ADRB2 (0.80) PDE4BKDM4EALDH1A1KMT2ARAD52
SCHEMBL5013043 0.78 ADRB2 (0.82) PDE4BKDM4ELMNAALDH1A1KMT2A
SCHEMBL5014745 0.78 PDE4B (0.91) PDE4BKDM4EALDH1A1KMT2ARAD52
SCHEMBL5014730 0.78 PDE4B (0.65) PDE4BKDM4ELMNAALDH1A1KMT2A
SCHEMBL5011551 0.78 KMT2A (0.80) PDE4BKDM4ELMNAKMT2ARAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080207645-A1 Pyridothienopyrimidine Derivatives PAGES SANTACANA LUIS MIGUEL 2008-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207645-A1 Pyridothienopyrimidine Derivatives PDE4A, PDE5A, PDE3B PDE4B 5/4885KDM4E 1526/4885LMNA 2537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.